Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

    Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
    e2022025
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.025
    1856
    PDF: 612
    HTML: 353
  • Massive pulmonary embolism at the onset of acute promyelocytic leukemia

    Federica Sorà, Patrizia Chiusolo, Luca Laurenti
    e2016027
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.027
    3604
    PDF: 919
    HTML: 1688
    figure 1: 189
    Untitled: 212
  • THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti
    e2013027
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.027
    2275
    PDF: 1066
    HTML: 2737
  • PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

    matteo molica, elisabetta abruzzese, massimo breccia
    e2020062
    2020-09-12
    https://doi.org/10.4084/mjhid.2020.062
    4137
    PDF: 1669
    HTML: 820
  • DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

    Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
    e2023008
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.008
    1459
    PDF: 1301
    HTML: 517
  • Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

    Serdar Sivgin
    e2013006
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.006
    1201
    PDF: 656
    HTML: 3345
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    810
    PDF: 622
    HTML: 53
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1563
    PDF: 577
    HTML: 254
  • DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA

    Sudhansu Sekhar Nishank
    e2015046
    2015-07-02
    https://doi.org/10.4084/mjhid.2015.046
    1626
    PDF: 818
    HTML: 1529
    Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 198
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

    Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava
    e2011056
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.056
    3765
    PDF: 985
    HTML: 4493
  • Successful treatment of de novo acute myeloid leukaemia associated aortitis by induction chemotherapy alone

    Urbain Tauveron--Jalenques, Vincent Grobost, Benoît Magnin, Cécile Moluçon-Chabrot, Jacques-Olivier Bay, Olivier Tournilhac; Romain Guièze
    e2024025
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.025
    708
    PDF: 1120
    HTML: 125
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1309
    PDF: 547
    HTML: 23155
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    1185
    PDF: 622
    Suppl. Files: 142
    HTML: 480
  • ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS

    saveria capria, silvia maria trisolini, clara minotti, caterina stefanizzi, luisa cardarelli, Martina Canichella, claudio cartoni, daniela diverio, maria stefania de propris, marco mancini, alessandra micozzi, robin foà, giovanna meloni
    e2012072
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.072
    1739
    PDF: 850
    HTML: 964
    cover letter: 300
  • PROGNOSTIC SIGNIFICANCE AND TREATMENT IMPLICATIONS OF MINIMAL RESIDUAL DISEASE STUDIES IN PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

    Orietta Spinelli, Manuela Tosi, Barbara Peruta, Marie Lorena Guinea Montalvo, Elena Maino, Anna Maria Scattolin, Margherita Parolini, Piera Viero, Alessandro Rambaldi, Renato Bassan
    e2014062
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.062
    2465
    PDF: 1127
    HTML: 5203
  • Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

    Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain
    e2010012
    2010-05-31
    https://doi.org/10.4084/mjhid.2010.012
    1104
    PDF: 713
    HTML: 377
  • HEMATOLOGICAL CHARACTERISTICS OF YEMENI ADULTS AND CHILDREN WITH VISCERAL LEISHMANIASIS. COULD EOSINOPENIA BE A SUSPICION INDEX?

    Jameel Al-Ghazaly, Waled Al-Dubai, Munasser Abdullah, Leila Al-Gharasi
    e2017056
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.056
    3522
    PDF: 1280
    HTML: 1484
  • DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE

    avinash kumar singh, tulika seth, nita radhakrishnan, pravas mishra, manoranjan mahapatra, haraprasad pati
    e2013039
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.039
    2552
    PDF: 877
    HTML: 3601
    Diamond Blackfan Anemia: A Tertiary care centre experience: 359
  • Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

    Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni
    e2025045
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.045
    1800
    PDF: 1334
    HTML: 631
  • INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER

    Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano
    e2011069
    2011-12-22
    https://doi.org/10.4084/mjhid.2011.069
    3399
    PDF: 989
    HTML: 2991
101 - 120 of 120 items << < 1 2 3 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.